Ipilimumab: Additional Phase II data

Additional data from the double-blind Phase II 007 trial in 115 patients with

Read the full 137 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE